STERIS (STE) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

STERIS (STE) overview

STERIS (STE) stock analysis and AI equity research. For financial year 2026, Valuatum's model shows revenue of USD 5,936m and operating profit of USD 1,102m; the year-end share price was 221.13 USD and market capitalisation was USD 21,627m. STERIS is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get STERIS's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 7,184mFY 2026
Share price221.13 USDFY 2026 year end
RevenueUSD 5,936mFY 2026
Operating profitUSD 1,102mFY 2026
Net earningsUSD 782mFY 2026
Market capitalisationUSD 21,627mFY 2026 year end

About STERIS

STERIS provides products and services supporting patient care and infection prevention, principally for healthcare providers and medical device and pharmaceutical customers. Its offerings include detergents, barrier products, instruments, sterilizers, surgical tables, and automated endoscope reprocessors. Services include equipment installation and maintenance, instrument and scope repair, laboratory testing, microbial reduction, and outsourced reprocessing. It also offers operating room connectivity solutions.

Generate the STERIS report

STERIS is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for STERIS and represent financial year 2026. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on STERIS

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.